SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending following its earnings report, which, despite beating estimates, led to a sell-off driven by higher-than-anticipated AI capital expenditures and a slight deceleration in Azure cloud growth, prompting community debate over long-term AI payoff versus immediate margin pressure.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending following its earnings, which revealed a significant strategic pivot from auto manufacturing, including the end of Model S/X production, towards a future centered on AI and robotics, sparking intense debate among investors about its ambitious new direction versus current financial metrics.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is seeing significant investor attention following its strong earnings beat and optimistic forward guidance, with community discourse swirling around its substantially increased capital expenditure on AI infrastructure; bulls view this as a strategic push for AI leadership, while bears remain wary of the massive investment's long-term returns.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is surging to new all-time highs, fueled by community discussion around persistent inflation, a weakening US dollar, and geopolitical tensions, with many seeing it as a flight to safety and a hedge against de-dollarization. While some fear a parabolic blow-off top, others emphasize sustained central bank accumulation as a key driver.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

Despite reporting strong financial results and a significant share repurchase, ServiceNow is trending down amidst a broader software sector sell-off, igniting community debate over market manipulation and the stock's long-term potential as an AI-driven enterprise leader.

Namib Minerals is a gold producer, developer and explorer with operations focused in Zimbabwe. The company was founded on June 5, 2025 and is headquartered in George Town, Cayman Islands.

Namib Minerals.

Namib Minerals

Namib Minerals is drawing significant investor attention amid gold's rally to new all-time highs. Community sentiment is focused on the stock's low float and high short interest, driving potential for a massive short squeeze, despite some users flagging concerns about trading restrictions and past dilution events.

Amentum Holdings, Inc. engages in mission-critical, technology-driven services in government and commercial markets. It operates through the Digital Solutions and Global Engineering Solutions segments. The Digital Solutions segment provides advanced digital and data-driven solutions including intelligence analytics, space system development, cybersecurity, and next generation IT. The Global Engineering Solutions segment manages large-scale environmental remediation, nuclear power solutions, platform engineering, sustainment and supply chain management. The company was founded on November 26, 2019 and is headquartered in Chantilly, VA.

Amentum Holdings Inc.

Amentum Holdings is surging after strong Q4 earnings, significant new contracts in nuclear energy and defense, and multiple analyst upgrades, igniting community excitement for its long-term potential despite past price volatility.

Sagimet Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for the treatment of infectious diseases. Its lead drug candidate, denifanstat, is an oral, once-daily pill and selective fatty acid synthase (FASN) inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH). The company was founded by Urs F. Greber, Ari Helenius, and Lucas Pelkmans on December 19, 2006 and is headquartered in San Mateo, CA.

Sagimet Biosciences Inc - Ordinary Shares - Series A

Sagimet Biosciences Inc

Sagimet Biosciences is currently trending following positive Phase 3 clinical trial results for its denifanstat in moderate-to-severe acne and the China NMPA's acceptance of the New Drug Application. The community is actively discussing the drug's blockbuster potential and its significantly undervalued market capitalization compared to recent MASH sector acquisitions, fueling speculation around a potential buyout.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is trending as community members are divided between seeing it as a deeply oversold buy, given new revenue streams like prediction markets and the potential for regulatory clarity, and others expressing extreme frustration over its prolonged downtrend and underperformance relative to Bitcoin, especially ahead of a critical White House meeting on crypto legislation.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BCRX is trending following the completion of its Astria Therapeutics acquisition, which integrated new assets and issued shares to former Astria holders, coinciding with a reported 9% Orladeyo price increase and 2025 revenue beat. The community's conversation centers on potential selling pressure from the newly issued shares and persistent frustration over perceived undervaluation, high short interest, and conservative 2026 guidance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ALT Best in class. Science dont lie  
 
&quot;These are industry leading results, compared to a cT1 reduction of 110ms with 15mg tirzepatide at 52 weeks. A cT1 reduction of 88ms is clinically significant for MASH resolution&quot; 
$MRK $ABBV $JNJ

Jim Patrick

Better DAYS

Chris

thaines1

Mike Smith

Colin Eskibashian

Salochin

lester

VINCE_CARTER

Formerly WilliamAnto

Mary OReilly

Robert Bockenfeld

Liviu Zamfir

Corpkcots

Mike D

Joseph Robbins

Stk Xprt

StockTwits Web

Altimmune Inc

Merck & Co Inc

Abbvie Inc

Johnson & Johnson

 Best in class. Science dont lie  
 
"These are industry leading results, compared to a cT1 reduction of 110ms with 15mg tirzepatide at 52 weeks. A cT1 reduction of 88ms is clinically significant for MASH resolution" 
